IL6 and diabetes mellitus: Indeed, patients with diabetes show high levels of pro-inflammatory cytokines such as tissue necrosis factor (TNF)-α, interleukin (IL)-1 and IL-6 compared to non-diabetic individuals and this higher baseline inflammatory state can worsen the clinical outcomes of patients with diabetes that undergo acute kidney damage (40, 140, 141).